JENNIFER ALEXANDER: Open Payments
NPI 1144844549 · MOODY, AL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,922 in 94 payments from 17 companies in 2025. Trend: 2023 $1,929 · 2024 $2,407 · 2025 $1,922
Food & beverage: $1,922
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 20 | $378 |
| Takeda Pharmaceuticals U.S.A., Inc. | 11 | $232 |
| Madrigal Pharmaceuticals | 10 | $223 |
| Janssen Biotech, Inc. | 9 | $175 |
| Ardelyx, Inc. | 7 | $164 |
| Phathom Pharmaceuticals, Inc. | 10 | $129 |
| QOL Medical, LLC | 4 | $101 |
| Regeneron Healthcare Solutions, Inc. | 3 | $83 |
| Celltrion USA Inc. | 4 | $78 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 4 | $69 |
Products named: ENTYVIO, REZDIFFRA, RINVOQ, TREMFYA, IBSRELA, DUPIXENT, VOQUEZNA, Sucraid.
Industry payments across AL — which companies pay providers there.
